Cargando…

DILI( C ): An AI-Based Classifier to Search for Drug-Induced Liver Injury Literature

Drug-induced liver injury (DILI) is a class of adverse drug reactions (ADR) that causes problems in both clinical and research settings. It is the most frequent cause of acute liver failure in the majority of Western countries and is a major cause of attrition of novel drug candidates. Manual trawli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rathee, Sanjay, MacMahon, Meabh, Liu, Anika, Katritsis, Nicholas M., Youssef, Gehad, Hwang, Woochang, Wollman, Lilly, Han, Namshik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277181/ https://www.ncbi.nlm.nih.gov/pubmed/35846129 http://dx.doi.org/10.3389/fgene.2022.867946

Ejemplares similares

dialogi: Utilising NLP With Chemical and Disease Similarities to Drive the Identification of Drug-Induced Liver Injury Literature
por: Katritsis, Nicholas M., et al.
Publicado: (2022)

Current and prospective computational approaches and challenges for developing COVID-19 vaccines
por: Hwang, Woochang, et al.
Publicado: (2021)

Identification of SARS-CoV-2–induced pathways reveals drug repurposing strategies
por: Han, Namshik, et al.
Publicado: (2021)

The Promise of AI for DILI Prediction
por: Vall, Andreu, et al.
Publicado: (2021)

Deriving time-concordant event cascades from gene expression data: A case study for Drug-Induced Liver Injury (DILI)
por: Liu, Anika, et al.
Publicado: (2022)

Identification of potential pan-coronavirus therapies using a computational drug repurposing platform
por: Hwang, Woochang, et al.
Publicado: (2022)

Computational Discovery of Cancer Immunotherapy Targets by Intercellular CRISPR Screens
por: Yim, Soorin, et al.
Publicado: (2022)

A comparison of RNA extraction and sequencing protocols for detection of small RNAs in plasma
por: Wong, Ryan K.Y., et al.
Publicado: (2019)

Prediction and mechanistic analysis of drug-induced liver injury (DILI) based on chemical structure
por: Liu, Anika, et al.
Publicado: (2021)

Biomarkers in DILI: One More Step Forward
por: Robles-Díaz, Mercedes, et al.
Publicado: (2016)

Mechanistic Studies of Idiosyncratic DILI: Clinical Implications
por: Uetrecht, Jack
Publicado: (2019)

AI-assisted ethics? considerations of AI simulation for the ethical assessment and design of assistive technologies
por: Schicktanz, Silke, et al.
Publicado: (2023)

Selection of a Real-Time PCR Housekeeping Gene Panel in Human Endothelial Colony Forming Cells for Cellular Senescence Studies
por: McLoughlin, Kiran J., et al.
Publicado: (2019)

Microphysiological Models for Mechanistic-Based Prediction of Idiosyncratic DILI
por: Stern, Sydney, et al.
Publicado: (2023)

Factors limiting immunization coverage in urban Dili, Timor-Leste
por: Amin, Ruhul, et al.
Publicado: (2013)

The DILI‐sim Initiative: Insights into Hepatotoxicity Mechanisms and Biomarker Interpretation
por: Watkins, Paul B.
Publicado: (2019)

Clinical management of patients with drug‐induced liver injury (DILI)
por: Björnsson, Einar S.
Publicado: (2021)

Landscape of DILI-related adverse drug reaction in China Mainland
por: Wang, Jiabo, et al.
Publicado: (2022)

It is time to classify biological aging as a disease
por: Bulterijs, Sven, et al.
Publicado: (2015)

Classifying Aging As a Disease: The Role of Microbes
por: Lustgarten, Michael S.
Publicado: (2016)

Causality Assessment for Suspected DILI During Clinical Phases of Drug Development
por: Regev, Arie, et al.
Publicado: (2014)

Genetic variations in drug-induced liver injury (DILI): resolving the puzzle
por: Stephens, Camilla, et al.
Publicado: (2012)

Metabolomic analysis to discriminate drug-induced liver injury (DILI) phenotypes
por: Quintás, Guillermo, et al.
Publicado: (2021)

The Potential Role of Metabolomics in Drug-Induced Liver Injury (DILI) Assessment
por: Moreno-Torres, Marta, et al.
Publicado: (2022)

Classifying aging as a disease in the context of ICD-11
por: Zhavoronkov, Alex, et al.
Publicado: (2015)

Metagenomic Geolocation Prediction Using an Adaptive Ensemble Classifier
por: Anyaso-Samuel, Samuel, et al.
Publicado: (2021)

Classifying and Evaluating Fetuses With Ventriculomegaly in Genetic Etiologic Studies
por: Cai, Meiying, et al.
Publicado: (2021)

In Search of Homo Deus
por: Katritsis, Demosthenes G
Publicado: (2020)

The AEO, an Ontology of Anatomical Entities for Classifying Animal Tissues and Organs
por: Bard, Jonathan B. L.
Publicado: (2012)

Machine Learning Classifiers for Endometriosis Using Transcriptomics and Methylomics Data
por: Akter, Sadia, et al.
Publicado: (2019)

Explainability in medicine in an era of AI-based clinical decision support systems
por: Pierce, Robin L., et al.
Publicado: (2022)

Mechanistic Modeling Reveals the Critical Knowledge Gaps in Bile Acid–Mediated DILI
por: Woodhead, J L, et al.
Publicado: (2014)

Models of Drug Induced Liver Injury (DILI) – Current Issues and Future Perspectives
por: Kuna, Lucija, et al.
Publicado: (2018)

Overview of Causality Assessment for Drug-Induced Liver Injury (DILI) in Clinical Trials
por: Hey-Hadavi, Juliana, et al.
Publicado: (2021)

Mechanism of idiosyncratic drug induced liver injury (DILI): unresolved basic issues
por: Teschke, Rolf, et al.
Publicado: (2021)

Comment: Drug-Induced Liver Injury (DILI) With Micafungin: The Importance of Causality Assessment
por: Danjuma, Mohammed, et al.
Publicado: (2020)

Role of Hepatocyte Transporters in Drug-Induced Liver Injury (DILI)—In Vitro Testing
por: Tátrai, Péter, et al.
Publicado: (2022)

Classifying hadronic objects in ATLAS with ML/AI algorithms
por: Sardain, Jad Mathieu
Publicado: (2023)

Classifying Breast Cancer Molecular Subtypes by Using Deep Clustering Approach
por: Rohani, Narjes, et al.
Publicado: (2020)

Development and validation of a robust necroptosis related classifier for colon adenocarcinoma
por: Yang, Jie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_limaqq7q3h5pfic4dnqb73ib4m